Open AccessTHE VALUE OF OSTEOPONTIN AS A DIAGNOSTIC BIOMARKER IN POSTMENOPAUSAL OSTEOPOROSIS; A REVIEW.
Author(s) -
Amira Atta
Publication year - 2020
Publication title -
journal of applied pharmacy
Language(s) - English
Resource type - Journals
ISSN - 1920-4159
DOI - 10.21065/19204159.12.27
Subject(s) - osteoporosis , osteopontin , medicine , bone mineral , biomarker , dual energy x ray absorptiometry , dual energy , omics , postmenopausal women , osteoporotic fracture , postmenopausal osteoporosis , bioinformatics , biology , biochemistry
Although increased awareness of morbidity and costs related to osteoporotic fractures, real progress achieved only through early detection of osteoporosis before any fractures occur. Dual Energy X-ray Absorptiometry (DEXA) is commonly used for diagnosis of osteoporosis by measuring bone mineral density (BMD
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom